Aspira Women's Health Inc.
AWHL· OTC
AWHLAspira Women's Health Inc.
Released May 15, 2026, after the close
10-Q filed May 15, 2026, 45 days after period end · 0000926617-26-000033
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|---|
| Revenue | $1.97M | $2.28M | $2.15M | $2.32M |
| Net Income | $676.00K | -$1.85M | -$4.63M | -$6.58M |
| EPS Diluted | -$0.05 |
Aspira Women's Health Inc. · CIK 926617 · Engraved from SEC EDGAR
| -$0.09 |
| -$0.39 |
| -$0.79 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
